ALDH1A1

Last updated
ALDH1A1
PDB 1bxs EBI.jpg
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases ALDH1A1 , ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e, HEL12, PUMB1, RALDH1, aldehyde dehydrogenase 1 family member A1
External IDs OMIM: 100640; MGI: 1353450; HomoloGene: 110441; GeneCards: ALDH1A1; OMA:ALDH1A1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000689

NM_013467

RefSeq (protein)

NP_000680

NP_038495
NP_001348432
NP_001348433
NP_001348434
NP_001348435

Contents

Location (UCSC) Chr 9: 72.9 – 73.08 Mb Chr 19: 20.49 – 20.64 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Aldehyde dehydrogenase 1 family, member A1, also known as ALDH1A1 or retinaldehyde dehydrogenase 1 (RALDH1), is an enzyme that is encoded by the ALDH1A1 gene. [5] [6]

Function

This protein belongs to the aldehyde dehydrogenases family of proteins and is a member of the ALDH1 subfamily (including ALDH1A2, ALDH1A3, ALDH1B1, ALDH2). Aldehyde dehydrogenase isozymes are NAD(P)-dependent dehydrogenases that catalyze the oxidation of an aldehyde into the corresponding carboxylic acid while reducing NAD+ or NADP+. ALDH1A1 is the only ALDH1 isozyme known to oxidize 9-cis retinaldehyde into 9-cis retinoic acid [7] and thus serve as the only known activator of the rexinoid nuclear receptor pathway [8] . ALDH1A1 has also been described with activity against other substrates in living systems, including all-trans retinaldehyde [9] as well as oxazaphosphorine, a cyclophosphamide metabolite [10] . Unique among the ALDH1 isozymes, ALDH1A1 is known to possess esterase activity in biochemical studies [11] , although it is unclear whether this is functionally relevant living tissues.

ALDH1A1 is expressed predominantly in metabolic tissues, including the liver, gastrointestinal tract, thyroid, pituitary gland, and adipose tissues [12] . ALDH1A1 is also expressed in the testes where its function in spermatogenesis is subordinate to and compensatory for ALDH1A2 in mice [9] . ALDH1A1 is inhibited by Antabuse (disulfiram) [13] , though the primary pharmacologic target of disulfiram in clinical use is ALDH2. The long clinical history of disulfiram use suggests that ALDH1A1 is not important to normal human physiology.

Clinical Significance

Obesity

The removal of ALDH1A1 in mice through genetic knockout results in viable animals that are fertile and healthy. The only validated phenotype of these mice is a resistance to high fat diet-induced obesity [14] while whole body ALDH1A1 removal does not affect fertility or neurological function. This biology closely replicates the clinical profile of Antabuse (disulfiram). Disulfiram and other ALDH1A1 inhibitors have been shown to cause ALDH1A1-dependent weight loss in obese animals [15] . This has increased interest in disulfiram as an alternative weight loss therapy to Ozempic [16] , yet the rare but potentially fatal liver-damaging effects of disulfiram due to its broad lack of selectivity as well as the alcohol-disulfiram reaction make it unattractive as a weight loss therapy [17] . Subsequent efforts to produce ALDH1A1-specific inhibitors have resulted in preclinical compounds that induce weight loss through increased metabolic activity [18] .

Errors Due to Historical Nomenclature

ALDH1A1 is often attributed with multiple biological roles as studies prior to human genome sequencing operated under the assumption that only one ALDH1 gene existed rather than the five isozymes that are annotated today [19] . Accordingly, ALDH1A1 is often attributed with a role in alcohol metabolism through oxidation of acetaldehyde, however, single nucleotide polymorphisms (SNPs) in this enzyme show little evidence of linkage to alcoholism in humans. [20] [21] Despite established naming conventions [19] , many studies still incorrectly use ALDH1 to describe the family of isozymes. For instance, many cancers studies have been interpreted to report on ALDH1A1 activity when the actual protein was ALDH1A3 [22] .

Species-Specific Expression

ALDH1A1 possesses unique taxon-specific traits across mammals. Found uniquely in rabbits compared to other mammals, ALDH1A1 appears to function as a corneal crystallin that helps to maintain the transparency of the cornea. In other species such as humans, this role is performed by ALDH3A1 [23] . In beavers, the ALDH1A1 gene has undergone genomic expansion, resulting in approximately 10 copies of the genomic locus, which is putatively linked to a role in lipid balance [24] .

Related Research Articles

<span class="mw-page-title-main">Alcohol dehydrogenase</span> Group of dehydrogenase enzymes

Alcohol dehydrogenases (ADH) (EC 1.1.1.1) are a group of dehydrogenase enzymes that occur in many organisms and facilitate the interconversion between alcohols and aldehydes or ketones with the reduction of nicotinamide adenine dinucleotide (NAD+) to NADH. In humans and many other animals, they serve to break down alcohols that are otherwise toxic, and they also participate in the generation of useful aldehyde, ketone, or alcohol groups during the biosynthesis of various metabolites. In yeast, plants, and many bacteria, some alcohol dehydrogenases catalyze the opposite reaction as part of fermentation to ensure a constant supply of NAD+.

<span class="mw-page-title-main">Disulfiram</span> Chemical compound

Disulfiram is a medication used to support the treatment of chronic alcoholism by producing an acute sensitivity to ethanol. Disulfiram works by inhibiting the enzyme aldehyde dehydrogenase, causing many of the effects of a hangover to be felt immediately following alcohol consumption. Disulfiram plus alcohol, even small amounts, produces flushing, throbbing in the head and neck, a throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, fast heart rate, low blood pressure, fainting, marked uneasiness, weakness, vertigo, blurred vision, and confusion. In severe reactions there may be respiratory depression, cardiovascular collapse, abnormal heart rhythms, heart attack, acute congestive heart failure, unconsciousness, convulsions, and death.

<span class="mw-page-title-main">Acetaldehyde dehydrogenase</span> Class of enzymes

Acetaldehyde dehydrogenases are dehydrogenase enzymes which catalyze the conversion of acetaldehyde into acetyl-CoA. This can be summarized as follows:

<span class="mw-page-title-main">Alcohol flush reaction</span> Effect of alcohol consumption on the human body

Alcohol flush reaction is a condition in which a person develops flushes or blotches associated with erythema on the face, neck, shoulders, ears, and in some cases, the entire body after consuming alcoholic beverages. The reaction is the result of an accumulation of acetaldehyde, a metabolic byproduct of the catabolic metabolism of alcohol, and is caused by an aldehyde dehydrogenase 2 deficiency.

<span class="mw-page-title-main">Alcohol tolerance</span> Bodily responses to the functional effects of ethanol in alcoholic beverages

Alcohol tolerance refers to the bodily responses to the functional effects of ethanol. This includes direct tolerance, speed of recovery from insobriety and resistance to the development of alcohol use disorder.

<span class="mw-page-title-main">Retinoic acid</span> Metabolite of vitamin A

Retinoic acid (simplified nomenclature for all-trans-retinoic acid) is a metabolite of vitamin A1 (all-trans-retinol) that is required for embryonic development, male fertility, regulation of bone growth and immune function. All-trans-retinoic acid is required for chordate animal development, which includes all higher animals from fish to humans. During early embryonic development, all-trans-retinoic acid generated in a specific region of the embryo helps determine position along the embryonic anterior/posterior axis by serving as an intercellular signaling molecule that guides development of the posterior portion of the embryo. It acts through Hox genes, which ultimately control anterior/posterior patterning in early developmental stages. In adult tissues, the activity of endogenous retinoic acid appears limited to immune function. and male fertility. Retinoic acid administered as a drug (see tretinoin and alitretinoin) causes significant toxicity that is distinct from normal retinoid biology.

<span class="mw-page-title-main">Aldehyde dehydrogenase</span> Group of enzymes

Aldehyde dehydrogenases are a group of enzymes that catalyse the oxidation of aldehydes. They convert aldehydes to carboxylic acids. The oxygen comes from a water molecule. To date, nineteen ALDH genes have been identified within the human genome. These genes participate in a wide variety of biological processes including the detoxification of exogenously and endogenously generated aldehydes.

<span class="mw-page-title-main">FOXC2</span> Protein-coding gene in the species Homo sapiens

Forkhead box protein C2 (FOXC2) also known as forkhead-related protein FKHL14 (FKHL14), transcription factor FKH-14, or mesenchyme fork head protein 1 (MFH1) is a protein that in humans is encoded by the FOXC2 gene. FOXC2 is a member of the fork head box (FOX) family of transcription factors.

<span class="mw-page-title-main">Pyruvate dehydrogenase kinase</span> Class of enzymes

Pyruvate dehydrogenase kinase is a kinase enzyme which acts to inactivate the enzyme pyruvate dehydrogenase by phosphorylating it using ATP.

<span class="mw-page-title-main">ALDH2</span> Enzyme

Aldehyde dehydrogenase, mitochondrial is an enzyme that in humans is encoded by the ALDH2 gene located on chromosome 12. ALDH2 belongs to the aldehyde dehydrogenase family of enzymes. Aldehyde dehydrogenase is the second enzyme of the major oxidative pathway of alcohol metabolism. ALDH2 has a low Km for acetaldehyde, and is localized in mitochondrial matrix. The other liver isozyme, ALDH1, localizes to the cytosol.

<span class="mw-page-title-main">Retinal dehydrogenase</span>

In enzymology, a retinal dehydrogenase, also known as retinaldehyde dehydrogenase (RALDH), catalyzes the chemical reaction converting retinal to retinoic acid. This enzyme belongs to the family of oxidoreductases, specifically the class acting on aldehyde or oxo- donor groups with NAD+ or NADP+ as acceptor groups, the systematic name being retinal:NAD+ oxidoreductase. This enzyme participates in retinol metabolism. The general scheme for the reaction catalyzed by this enzyme is:

<span class="mw-page-title-main">SRD5A1</span> Protein-coding gene in the species Homo sapiens

3-Oxo-5α-steroid 4-dehydrogenase 1 is an enzyme that in humans is encoded by the SRD5A1 gene. It is one of three forms of steroid 5α-reductase.

<span class="mw-page-title-main">Aldehyde dehydrogenase 3 family, member A1</span> Protein-coding gene in the species Homo sapiens

Aldehyde dehydrogenase, dimeric NADP-preferring is an enzyme that in humans is encoded by the ALDH3A1 gene.

<span class="mw-page-title-main">ADH1A</span> Protein-coding gene in the species Homo sapiens

Alcohol dehydrogenase 1A is an enzyme that in humans is encoded by the ADH1A gene.

<span class="mw-page-title-main">ALDH1A2</span> Protein-coding gene in the species Homo sapiens

Aldehyde dehydrogenase 1 family, member A2, also known as ALDH1A2 or retinaldehyde dehydrogenase 2 (RALDH2), is an enzyme that in humans is encoded by the ALDH1A2 gene.

<span class="mw-page-title-main">Aldehyde dehydrogenase 9 family, member A1</span> Protein-coding gene in the species Homo sapiens

4-trimethylaminobutyraldehyde dehydrogenase is an enzyme that in humans is encoded by the ALDH9A1 gene.

<span class="mw-page-title-main">ALDH3B1</span> Protein-coding gene in the species Homo sapiens

Aldehyde dehydrogenase 3 family, member B1 also known as ALDH3B1 is an enzyme that in humans is encoded by the ALDH3B1 gene.

<span class="mw-page-title-main">ALDH1A3</span> Protein-coding gene in the species Homo sapiens

Aldehyde dehydrogenase 1 family, member A3 (ALDH1a3), also known as retinaldehyde dehydrogenase 3 (RALDH3) or as ALDH6 in earlier published studies, is an enzyme that in humans is encoded by the ALDH1A3 gene.,

<span class="mw-page-title-main">Alcohol intolerance</span> Medical condition

Alcohol intolerance is due to a genetic polymorphism of the aldehyde dehydrogenase enzyme, which is responsible for the metabolism of acetaldehyde. This polymorphism is most often reported in patients of East Asian descent. Alcohol intolerance may also be an associated side effect of certain drugs such as disulfiram, metronidazole, or nilutamide. Skin flushing and nasal congestion are the most common symptoms of intolerance after alcohol ingestion. It may also be characterized as intolerance causing hangover symptoms similar to the "disulfiram-like reaction" of aldehyde dehydrogenase deficiency or chronic fatigue syndrome. Severe pain after drinking alcohol may indicate a more serious underlying condition.

<span class="mw-page-title-main">Disulfiram-like drug</span> Drug that causes an adverse reaction to alcohol

A disulfiram-like drug is a drug that causes an adverse reaction to alcohol leading to nausea, vomiting, flushing, dizziness, throbbing headache, chest and abdominal discomfort, and general hangover-like symptoms among others. These effects are caused by accumulation of acetaldehyde, a major but toxic metabolite of alcohol formed by the enzyme alcohol dehydrogenase. The reaction has been variously termed a disulfiram-like reaction, alcohol intolerance, and acetaldehyde syndrome.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000165092 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000053279 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Pereira F, Rosenmann E, Nylen E, Kaufman M, Pinsky L, Wrogemann K (March 1991). "The 56 kDa androgen binding protein is an aldehyde dehydrogenase". Biochemical and Biophysical Research Communications. 175 (3): 831–8. doi:10.1016/0006-291X(91)91640-X. PMID   1709013.
  6. Hsu LC, Tani K, Fujiyoshi T, Kurachi K, Yoshida A (June 1985). "Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2". Proceedings of the National Academy of Sciences of the United States of America. 82 (11): 3771–5. Bibcode:1985PNAS...82.3771H. doi: 10.1073/pnas.82.11.3771 . PMC   397869 . PMID   2987944.
  7. Labrecque, J; Dumas, F; Lacroix, A; Bhat, P V (1995-01-15). "A novel isoenzyme of aldehyde dehydrogenase specifically involved in the biosynthesis of 9-cis and all-trans retinoic acid". Biochemical Journal. 305 (2): 681–684. doi:10.1042/bj3050681. ISSN   0264-6021. PMC   1136415 . PMID   7832787.
  8. Esposito, Mark; Amory, John K.; Kang, Yibin (2024-08-12). "The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes". Journal of Experimental Medicine. 221 (9): e20240519. doi:10.1084/jem.20240519. ISSN   0022-1007. PMC   11318670 . PMID   39133222.
  9. 1 2 Topping, Traci; Griswold, Michael D. (2022). "Global Deletion of ALDH1A1 and ALDH1A2 Genes Does Not Affect Viability but Blocks Spermatogenesis". Frontiers in Endocrinology. 13: 871225. doi: 10.3389/fendo.2022.871225 . ISSN   1664-2392. PMC   9097449 . PMID   35574006.
  10. Sládek, Norman E.; Kollander, Rahn; Sreerama, Lakshmaiah; Kiang, David T. (2002-04-01). "Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study". Cancer Chemotherapy and Pharmacology. 49 (4): 309–321. doi:10.1007/s00280-001-0412-4. ISSN   1432-0843.
  11. Koppaka, Vindhya; Thompson, David C.; Chen, Ying; Ellermann, Manuel; Nicolaou, Kyriacos C.; Juvonen, Risto O.; Petersen, Dennis; Deitrich, Richard A.; Hurley, Thomas D.; Vasiliou, Vasilis (2012-07-01). Sibley, David R. (ed.). "Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application". Pharmacological Reviews. 64 (3): 520–539. doi:10.1124/pr.111.005538. ISSN   0031-6997. PMC   3400832 . PMID   22544865.
  12. "Tissue expression of ALDH1A1 - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2024-12-03.
  13. Omran, Ziad (2022-01-12). "Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors". Molecules (Basel, Switzerland). 27 (2): 480. doi: 10.3390/molecules27020480 . ISSN   1420-3049. PMC   8778300 . PMID   35056791.
  14. Kiefer, Florian W.; Vernochet, Cecile; O'Brien, Patrick; Spoerl, Steffen; Brown, Jonathan D.; Nallamshetty, Shriram; Zeyda, Maximilian; Stulnig, Thomas M.; Cohen, David E.; Kahn, C. Ronald; Plutzky, Jorge (June 2012). "Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue". Nature Medicine. 18 (6): 918–925. doi:10.1038/nm.2757. ISSN   1546-170X. PMC   3792792 . PMID   22561685.
  15. Bernier, Michel; Mitchell, Sarah J.; Wahl, Devin; Diaz, Antonio; Singh, Abhishek; Seo, Wonhyo; Wang, Mingy; Ali, Ahmed; Kaiser, Tamzin; Price, Nathan L.; Aon, Miguel A.; Kim, Eun-Young; Petr, Michael A.; Cai, Huan; Warren, Alessa (2020-08-04). "Disulfiram Treatment Normalizes Body Weight in Obese Mice". Cell Metabolism. 32 (2): 203–214.e4. doi:10.1016/j.cmet.2020.04.019. ISSN   1550-4131. PMC   7957855 . PMID   32413333.
  16. "Repurposed drug helps obese mice lose weight, improve metabolic function". National Institutes of Health (NIH). 2020-05-14. Retrieved 2024-12-03.
  17. "Disulfiram: Package Insert / Prescribing Information". Drugs.com. Retrieved 2024-12-03.
  18. Haenisch, Michael; Treuting, Piper M.; Brabb, Thea; Goldstein, Alex S.; Berkseth, Kathryn; Amory, John K.; Paik, Jisun (2018-01-01). "Pharmacological inhibition of ALDH1A enzymes suppresses weight gain in a mouse model of diet-induced obesity". Obesity Research & Clinical Practice. 12 (1): 93–101. doi:10.1016/j.orcp.2017.08.003. ISSN   1871-403X. PMC   5816716 . PMID   28919001.
  19. 1 2 Vasiliou, V.; Bairoch, A.; Tipton, K. F.; Nebert, D. W. (August 1999). "Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping". Pharmacogenetics. 9 (4): 421–434. ISSN   0960-314X. PMID   10780262.
  20. Sherva R, Rice JP, Neuman RJ, Rochberg N, Saccone NL, Bierut LJ (May 2009). "Associations and interactions between SNPs in the alcohol metabolizing genes and alcoholism phenotypes in European Americans". Alcoholism: Clinical and Experimental Research. 33 (5): 848–57. doi:10.1111/j.1530-0277.2009.00904.x. PMC   2892966 . PMID   19298322.
  21. Liu J, Zhou Z, Hodgkinson CA, Yuan Q, Shen PH, Mulligan CJ, et al. (February 2011). "Haplotype-based study of the association of alcohol-metabolizing genes with alcohol dependence in four independent populations". Alcoholism: Clinical and Experimental Research. 35 (2): 304–16. doi:10.1111/j.1530-0277.2010.01346.x. PMC   3026908 . PMID   21083667.
  22. Ginestier, Christophe; Hur, Min Hee; Charafe-Jauffret, Emmanuelle; Monville, Florence; Dutcher, Julie; Brown, Marty; Jacquemier, Jocelyne; Viens, Patrice; Kleer, Celina G.; Liu, Suling; Schott, Anne; Hayes, Dan; Birnbaum, Daniel; Wicha, Max S.; Dontu, Gabriela (2007-11-15). "ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome". Cell Stem Cell. 1 (5): 555–567. doi:10.1016/j.stem.2007.08.014. ISSN   1934-5909. PMC   2423808 . PMID   18371393.
  23. Jester JV, Moller-Pedersen T, Huang J, Sax CM, Kays WT, Cavangh HD, et al. (March 1999). "The cellular basis of corneal transparency: evidence for 'corneal crystallins'". Journal of Cell Science. 112. 112 (5): 613–22. doi:10.1242/jcs.112.5.613. PMID   9973596.
  24. Zhang, Quanwei; Tombline, Gregory; Ablaeva, Julia; Zhang, Lei; Zhou, Xuming; Smith, Zachary; Zhao, Yang; Xiaoli, Alus M.; Wang, Zhen; Lin, Jhih-Rong; Jabalameli, M. Reza; Mitra, Joydeep; Nguyen, Nha; Vijg, Jan; Seluanov, Andrei (2021-11-09). "Genomic expansion of Aldh1a1 protects beavers against high metabolic aldehydes from lipid oxidation". Cell Reports. 37 (6): 109965. doi:10.1016/j.celrep.2021.109965. ISSN   2211-1247. PMC   8656434 . PMID   34758328.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.